Focused Ultrasound Mediated Opening of the Blood-Brain Barrier for Neurodegenerative Diseases
Date
2021-11-04Journal
Frontiers in NeurologyPublisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordAbstract
The blood brain barrier (BBB) is an obstacle for the delivery of potential molecular therapies for neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS). Although there has been a proliferation of potential disease modifying therapies for these progressive conditions, strategies to deliver these large agents remain limited. High intensity MRI guided focused ultrasound has already been FDA approved to lesion brain targets to treat movement disorders, while lower intensity pulsed ultrasound coupled with microbubbles commonly used as contrast agents can create transient safe opening of the BBB. Pre-clinical studies have successfully delivered growth factors, antibodies, genes, viral vectors, and nanoparticles in rodent models of AD and PD. Recent small clinical trials support the safety and feasibility of this strategy in these vulnerable patients. Further study is needed to establish safety as MRI guided BBB opening is used to enhance the delivery of newly developed molecular therapies.Rights/Terms
Copyright © 2021 Fishman and Fischell.Identifier to cite or link to this item
http://hdl.handle.net/10713/17255ae974a485f413a2113503eed53cd6c53
10.3389/fneur.2021.749047
Scopus Count
Collections
Related articles
- "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases".
- Authors: Wasielewska JM, White AR
- Issue date: 2022 Mar
- Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders.
- Authors: Stavarache MA, Chazen JL, Kaplitt MG
- Issue date: 2021 Jan
- Magnetic Resonance-Guided Focused Ultrasound : Current Status and Future Perspectives in Thermal Ablation and Blood-Brain Barrier Opening.
- Authors: Lee EJ, Fomenko A, Lozano AM
- Issue date: 2019 Jan
- Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?
- Authors: Stefani A, Pierantozzi M, Cardarelli S, Stefani L, Cerroni R, Conti M, Garasto E, Mercuri NB, Marini C, Sucapane P
- Issue date: 2022
- Ultrasound-induced blood-brain barrier opening.
- Authors: Konofagou EE, Tung YS, Choi J, Deffieux T, Baseri B, Vlachos F
- Issue date: 2012 Jun